What is Dexcare?
Dexcare is a data-driven intelligence company incubated within Providence, one of the nation's largest health systems. Its core offering is a software platform exclusively provided to health systems, designed to orchestrate digital demand and healthcare capacity across all lines of care. The platform aims to enhance consumer access to healthcare by providing a seamless, digitized, and unified experience, thereby amplifying existing EMR, caregiver, and brand investments. Dexcare's unique value proposition lies in its intelligent navigation and load balancing capabilities across various providers, settings, modalities, and service lines. Its data-driven engine optimizes resources to meet both consumer demand and health system business objectives. The platform has demonstrated significant success, attracting more new patients (30% increase), a high percentage of whom are commercially insured (85%), capturing substantial downstream revenue (8x), generating cost savings (over 20% per patient encounter), and achieving high patient satisfaction (Net Promoter Score >90%).
How much funding has Dexcare raised?
Dexcare has raised a total of $75M across 1 funding round:
Series C
$75M
Series C (2023): $75M with participation from ICONIQ Growth, Kaiser Permanente, and Transformation Capital
Key Investors in Dexcare
ICONIQ Growth
ICONIQ Growth is a venture capital firm that partners with entrepreneurs to drive global impact. They focus on building enduring company cultures and leverage a vibrant ecosystem to amplify portfolio companies' success from early growth stages through IPO.
Kaiser Permanente
Kaiser Permanente is a leading not-for-profit integrated healthcare organization providing comprehensive medical services. They focus on patient-centered care, preventive measures, and improving health outcomes through their extensive network of hospitals and clinics.
Transformation Capital
Transformation Capital is a growth equity fund established in 2015, exclusively focused on investing in innovative healthcare IT and services companies.
What's next for Dexcare?
With a major strategic investment and substantial total funding, Dexcare is well-positioned for accelerated growth and market expansion. The company's focus on optimizing healthcare access through its data-driven platform is critical in the current healthcare landscape. Future endeavors will likely involve further enhancing its platform's capabilities, expanding its reach to more health systems, and leveraging its data intelligence to drive greater efficiency and patient satisfaction. This significant capital infusion will support ongoing innovation, talent acquisition, and strategic partnerships, solidifying Dexcare's role as a leader in healthcare technology.
See full Dexcare company page
